Novel Vaccines for Porcine Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 268
Special Issue Editors
Interests: porcine viruses; coronaviruses; vaccines; PEDV; PRRSC; mink viruses; antivirals
Special Issues, Collections and Topics in MDPI journals
Interests: veterinary vaccines; adenovirus; porcine reproductive and respiratory virus
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Intensive pig farming can lead to outbreaks of viral diseases, which is a critical concern for animal welfare, the economy, food security, and an increase in the use of antibiotics. Vaccination has been proven to be the most effective measure for disease control. Commercial vaccines are currently available to control porcine viruses such as circovirus, porcine epidemic diarrhoea virus (PEDV), parvovirus, swine influenza virus (SIV), porcine reproductive and respiratory syndrome virus (PRRSV), and foot-and-mouth disease virus. Vaccines against African swine fever virus tested in Vietnam are close to being approved. However, some of the currently used vaccines require improvement. For instance, modified live vaccines against PRRSV confer complete protection against homologous PRRSV strains, whereas heterologous protection is variable. Furthermore, the industry requires a “universal” SIV vaccine that protects pigs from a broad range of SIV strains. For some viruses, such as porcine rotaviruses (types B and C,) commercial vaccines are not available. Unfortunately, despite extensive vaccination campaigns aimed at controlling PEDV, the virus remains a major threat to the global swine industry. Several vaccine technologies and platforms can be used to construct novel vaccines against viral diseases of pigs. These technologies include inactivated (killed) and modified live vaccines, virus-like particles and subunit vaccines, synthetic peptides, nanoparticles, viral-vectored (vector-based) vaccines, nucleic acids (DNA and mRNA), and bacterial vectored vaccines.
In this Special Issue of Viruses, we invite research and review papers that contribute to the development of novel vaccines for porcine viruses.
Prof. Dr. Levon Abrahamyan
Dr. Alexander Zakhartchouk
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- porcine viruses
- porcine vaccines
- swine vaccines
- viral-vectored vaccines
- DNA and mRNA vaccines
- swine viral diseases
- vaccine development
